The Ratio of GrzB(+) − FoxP3(+) over CD3(+) T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma

SIMPLE SUMMARY: Despite the recent success of immunotherapy in the treatment of malignant melanoma, many patients still do not benefit from these treatments, due to their failure to activate an antitumor immune response them. There is therefore a need to select patients who can truly benefit from th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancers (Basel)
Main Authors: Scognamiglio, Giosuè, Capone, Mariaelena, Sabbatino, Francesco, Di Mauro, Annabella, Cantile, Monica, Cerrone, Margherita, Madonna, Gabriele, Grimaldi, Antonio Maria, Mallardo, Domenico, Palla, Marco, Sarno, Sabrina, Anniciello, Anna Maria, Di Bonito, Maurizio, Ascierto, Paolo Antonio, Botti, Gerardo
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150779/
https://ncbi.nlm.nih.gov/pubmed/34066146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102325
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker